DABIGATRAN ETEXILATE MESYLATE | A208040 | ALKEM LABORATORIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. TEVA PHARMACEUTICALS USA, INC. et al 1 patentANDA 208057, 208040, 208067dabigatran etexilate mesylate | D.N.J. | 2014-12-15 | Terminated 2018-01-26 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.